Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Cutaneous × aldesleukin × 1 year × Clear all

Sponsor

Conditions

Melanoma 14 Neoplasm Metastasis 9 Pancreatic Neoplasms 8 Ovarian Neoplasms 8 Stomach Neoplasms 7 Leukemia, Myeloid, Acute 6 Carcinoma, Renal Cell 6 Carcinoma, Non-Small-Cell Lung 6 Skin Neoplasms 5 Colorectal Neoplasms 5 Triple Negative Breast Neoplasms 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Rectal Neoplasms 3 Neuroblastoma 3 Myelodysplastic Syndromes 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Leukemia 3 Hematologic Neoplasms 3 Gastrointestinal Neoplasms 3 Colonic Neoplasms 3 Vulvar Neoplasms 2 Urogenital Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms 2 Lung Neoplasms 2 Leukemia, Myeloid 2

Interventions

Cyclophosphamide 7 Biopsy 6 romidepsin 5 mogamulizumab 5 fludarabine 5 Brentuximab Vedotin 5 pembrolizumab 4 fludarabine phosphate 4 Specimen Handling 4 Magnetic Resonance Spectroscopy 4 Immunoglobulin G 4 Disulfides 4 ruxolitinib 3 Peripheral Blood Stem Cell Transplantation 3 Nivolumab 3 Mycophenolic Acid 3 Lenalidomide 3 Depsipeptides 3 hypericin 2 belinostat 2 Whole-Body Irradiation 2 Tacrolimus 2 Melphalan 2 Lactones 2 Etoposide 2 Busulfan 2 Bexarotene 2 trastuzumab biosimilar HLX02 1 tofacitinib 1 thymoglobulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡